Pricing Log in Create free account

Annovis Bio, Inc. (ANVS) vs Dogwood Therapeutics, Inc (DWTX)

Annovis Bio, Inc. and Dogwood Therapeutics, Inc are both Biotechnology companies. Annovis Bio, Inc. and Dogwood Therapeutics, Inc are of similar size ($44.8M and $42.5M). Across the 8 metrics below, Dogwood Therapeutics, Inc leads on 6 and Annovis Bio, Inc. on 2.

Valuation

Metric ANVS DWTX Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B n/m 0.61 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (180.81%) (733.61%) (33.15%)
Free cash flow yield (116.68%) (36.28%) (25.50%)

Profitability

Metric ANVS DWTX Biotechnology median
Gross margin — — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (703.68%) (143.45%) (56.36%)
Return on assets (227.74%) (40.68%) (48.04%)
Return on invested capital 0.00% (41.22%) 0.00%

Growth

Metric ANVS DWTX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 39.39% 43.05% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANVS DWTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.47 3.89 4.72
Net debt to EBITDA 0.66 0.23 0.96

Dividend

Metric ANVS DWTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ANVS DWTX Biotechnology median
Market cap 44.81m 42.49m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack